Fundz

Unravel Biosciences, Inc. reported raising $500,000 in an initial SEC Form D filing, from an offering of $1 Million

PRIVATEAug 06, 2021

Amount Raised

$500,000

$500,000 sold, per SEC Form D (first sale Aug 6, 2021)

Round Type

Seed

BostonBiotechnology

Who to call at Unravel Biosciences, Inc., and when

A new round usually means Unravel Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Unravel Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Unravel Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Unravel Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Unravel Biosciences, Inc.

Location

100 WILLIAM T. MORRISSEY BLVD.

Boston, Massachusetts, United States

About

Diseases are a product of complex interactions among biological layers that we barely understand. Our platform integrates computational drug prediction with on-demand animal models and cutting-edge screening hardware to rapidly connect behavioral and cognitive symptoms to novel therapeutic targets and treatments in a matter of weeks. Unlike other discovery stage companies, Unravel enables unbiased identification of drug targets that span organ systems, including restoring metabolism and reducing inflammation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Unravel Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRichard N., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Unravel Biosciences, Inc.'s next move

See what Strategic adds

Unravel Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.